Abstract
Levamisole (the laevorotatory isomer of tetramisole) is a new synthetic anthelmintic. A cure rate of 91% was obtained in a series of 111 ascariasis-infected children treated with a single oral dose of the drug. The failures, who were treated with the drug a second time one week later, were all cured. In a comparative study of levamisole and piperazine citrate in a series of 100 children with ascariasis a cure rate of 92% and 90% was obtained with a single dose of levamisole and piperazine respectively, indicating equal efficacy. Levamisole is better tolerated than piperazine citrate and is virtually free of toxic effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bullock M. W., Hand J. J., Waletzky E. Resolution and racemization of dl-tetramisole, dl-6-phenyl-2,3,5,6-tetrahydroimidazo-[2,1-b]thiazole. J Med Chem. 1968 Jan;11(1):169–171. [PubMed] [Google Scholar]
- Raeymaekers A. H., Roevens L. F., Janssen P. A. The absolute configurations of the optical isomers of the broad spectrum anthelmintic tetramisole. Tetrahedron Lett. 1967 Apr;16:1467–1470. doi: 10.1016/s0040-4039(00)90983-3. [DOI] [PubMed] [Google Scholar]
- Van den Bossche H., Janssen P. A. The biochemical mechanism of action of the anthelmintic drug tetramisole. Life Sci. 1967 Aug 15;6(16):1781–1792. doi: 10.1016/0024-3205(67)90150-6. [DOI] [PubMed] [Google Scholar]